first
report
wuhan
china
decemb
ongo
outbreak
viral
pneumonia
human
rais
acut
grave
global
concern
caus
pathogen
rapidli
identifi
novel
coronaviru
sinc
formal
name
sever
acut
respiratori
syndrom
coronaviru
intern
committe
taxonomi
virus
accord
daili
report
nation
health
commiss
china
epidem
far
caus
confirm
case
includ
sever
case
death
china
februari
show
symptom
fever
dri
cough
fatigu
abnorm
chest
ct
find
good
prognosi
contrast
patient
develop
sever
pneumonia
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
death
rate
rang
accord
differ
studi
report
lymphopenia
inflammatori
cytokin
storm
typic
laboratori
abnorm
observ
highli
pathogen
coronaviru
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
believ
associ
diseas
sever
recent
studi
also
report
decreas
count
lymphocyt
peripher
blood
increas
serum
inflammatori
cytokin
written
inform
consent
regularli
obtain
patient
upon
admiss
wuhan
union
hospit
china
studi
approv
ethic
committe
tongji
medic
colleg
huazhong
univers
scienc
technolog
confirm
patient
wuhan
union
hospit
januari
januari
enrol
retrospect
singlecent
studi
medic
record
inform
includ
epidemiolog
demograph
clinic
manifest
laboratori
data
outcom
data
obtain
data
check
team
train
physician
laboratori
confirm
perform
local
cdc
accord
chines
cdc
protocol
throatswab
specimen
collect
patient
sampl
maintain
viraltransport
medium
laboratori
test
infect
respiratori
virus
includ
influenza
viru
influenza
b
viru
coxsacki
viru
respiratori
syncyti
viru
parainfluenza
viru
enteroviru
exclud
realtim
rtpcr
specimen
includ
sputum
alveolar
lavatori
fluid
blood
urin
fece
cultur
identifi
pathogen
bacteria
fungi
may
associ
infect
specif
igg
igm
chlamydia
pneumonia
mycoplasma
pneumonia
detect
chemiluminesc
immunoassay
lymphocyt
test
kit
beckman
coulter
inc
fl
usa
use
lymphocyt
subset
analysi
plasma
cytokin
detect
human
cytokin
kit
ii
bd
ltd
franklin
lake
nj
usa
test
perform
accord
product
manual
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
sever
patient
mild
patient
fever
signific
differ
degre
temperatur
observ
two
group
tabl
sever
patient
show
significantli
higher
frequenc
occurr
sputum
product
myalgia
nausea
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
signific
differ
serum
level
immunoglobulin
iga
igg
igm
complement
observ
two
group
tabl
lymphopenia
observ
mild
patient
sever
patient
onset
diseas
shown
tabl
absolut
count
lymphocyt
peripher
blood
sever
patient
significantli
lower
absolut
count
total
white
blood
cell
wbc
neutrophil
significantli
higher
mild
patient
time
hospit
admiss
signific
differ
monocyt
count
observ
two
group
tabl
next
analyz
kinet
chang
wbc
neutrophil
monocyt
well
differ
lymphocyt
subset
peripher
blood
patient
diseas
onset
least
day
later
two
mortal
sever
group
exclud
analysi
due
lack
kinet
data
signific
increas
total
wbc
count
sever
group
observ
time
point
onset
within
day
follow
period
diseas
progress
compar
mild
group
figur
signific
increas
neutrophil
count
sever
group
observ
time
point
diseas
onset
also
day
compar
mild
group
figur
contrast
sustain
decreas
lymphocyt
count
sever
group
observ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
compar
mild
patient
differ
signific
time
point
diseas
onset
becam
even
greater
day
later
figur
day
diseas
onset
lymphocyt
count
gradual
increas
sever
group
reach
compar
level
mild
patient
day
diseas
onset
figur
signific
differ
monocyt
count
observ
two
group
whole
observ
period
figur
order
determin
kinet
chang
differ
lymphocyt
subset
peripher
blood
patient
perform
flow
cytometri
stain
cell
cell
subset
b
cell
nk
cell
similar
find
lymphocyt
sustain
decreas
cell
count
observ
sever
group
compar
mild
patient
clinic
observ
differ
cell
count
two
group
signific
time
point
diseas
onset
day
later
figur
howev
differ
cell
count
two
group
reach
statist
signific
time
point
figur
cell
count
start
gradual
increas
sever
group
start
day
diseas
onset
reach
compar
level
mild
patient
day
diseas
onset
figur
c
signific
differ
b
cell
nk
cell
count
observ
two
group
whole
cours
diseas
figur
previou
studi
demonstr
chang
inflammatori
cytokin
level
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
serum
patient
therefor
character
kinet
chang
inflammatori
cytokin
level
includ
serum
patient
cohort
fluctuat
serum
level
cytokin
mild
patient
group
minor
contrast
sever
patient
group
show
signific
fluctuat
serum
level
cytokin
figur
examin
cytokin
except
reach
peak
level
serum
day
diseas
onset
figur
level
show
sustain
increas
sever
group
compar
mild
group
figur
deceas
serum
level
sever
group
start
day
diseas
onset
level
lowest
day
diseas
onset
figur
signific
increas
serum
level
sever
group
observ
day
diseas
onset
figur
signific
differ
level
observ
two
group
whole
cours
diseas
figur
examin
cytokin
reach
similar
level
sever
mild
patient
group
day
diseas
onset
figur
next
examin
possibl
use
abovement
paramet
prognost
factor
identifi
sever
case
patient
pca
firstli
perform
r
packag
factoextra
identifi
correl
variabl
distinguish
sever
patient
mild
patient
figur
four
mostli
neutrophiltolymphocyt
ratio
nlr
neutrophil
count
nec
white
blood
cell
count
wbcc
select
potenti
prognost
factor
detail
statist
analysi
assess
diagnost
valu
select
paramet
receiv
oper
characterist
roc
curv
area
roc
curv
auc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
studi
analyz
clinic
featur
immunolog
characterist
peripher
blood
patient
although
major
patient
exposur
histori
huanan
seafood
market
wuhan
clinic
characterist
patient
similar
report
previou
studi
age
sever
patient
older
proport
underli
diseas
higher
coinfect
also
occur
sever
patient
recent
report
show
lymphocyt
count
normal
patient
mild
diseas
contrast
patient
sever
diseas
lymphopenia
lymphocyt
count
patient
mortal
outcom
remain
low
level
studi
also
confirm
higher
rate
develop
lymphopenia
sever
patient
mild
patient
vs
found
develop
lymphopenia
sever
patient
mainli
relat
significantli
decreas
absolut
count
cell
especi
cell
b
cell
nk
cell
decreas
cell
sever
patient
group
reach
peak
within
first
week
diseas
cours
cell
number
gradual
increas
second
week
recov
compar
level
mild
patient
group
third
week
sever
patient
includ
studi
surviv
diseas
thu
specul
cours
associ
favor
outcom
sever
patient
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
result
demonstr
even
better
perform
higher
auc
valu
nlr
roc
curv
analysi
may
serv
power
factor
nlr
predict
sever
ill
incid
covid
patient
summari
studi
immunolog
characterist
peripher
blood
patient
show
number
neutrophil
cell
especi
cell
well
level
inflammatori
cytokin
peripher
blood
dynam
correl
sever
diseas
best
knowledg
first
work
describ
kinet
chang
lymphocyt
subset
cytokin
profil
patient
importantli
identifi
nlr
power
prognost
factor
earli
identif
sever
case
work
may
help
achiev
better
understand
immun
function
disord
well
immunopathogenesi
infect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
blood
potassium
mmoll
blood
sodium
mmoll
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
